Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038454 (
stroke
)
147,016
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Cardiovascular Health Study (CHS) analyzes risk factors for coronary heart disease and
stroke
in people age 65 and older. Since CHS is designed to comprehensively study cardiovascular risk factors in an elderly population, it provides a unique opportunity to study the association of risk factors with mortality, as well as morbidity risk. With the growth of the elderly as population and life insurance market segments, the need to more precisely stratify mortality within a standard risk group of the elderly has grown as well. This exploratory analysis assesses medical factors that could be used to improve mortality risk stratification within a "standard" mortality population, using the CHS public use data set. Participants with a personal history of cardiovascular disease, diabetes, or major electrocardiographic abnormalities were excluded from the analysis in order to mimic a standard life insurance selection process. Then, Cox proportional hazards regression was used to study 10 medical risk factors. This model suggested that forced vital capacity >80% predicted, serum creatinine <1.5 mg/dL (133 mcmol/L), hemoglobin >11 g/dL (110 g/L), and
serum albumin
>3.5 mg/L (35 mmol/ L) are significantly associated (p = 0.05) with favorable mortality. C-reactive protein <1 mg/L is associated with favorable mortality at borderline significance levels (p = 0.09). On the other hand, a family history of cardiovascular disease (MI and/or
stroke
) and low BMI (<26 kg/m2) are associated with unfavorable mortality in the analysis. Total to HDL cholesterol ratio of <6, presence of supine systolic blood pressure < or = 140 mmHg, and the presence of minor rest electrocardiographic findings were not statistically significant factors in the multivariate model. Further assessment of the predictive value of the "significant" medical factors identified is required in insured lives.
...
PMID:Screening potential elderly preferred markers: exploratory analysis of Cardiovascular Health Study (CHS) data. 1549 35
Human C-reactive protein (CRP), the classic acute phase plasma protein, increases in concentration after myocardial infarction and
stroke
. Human CRP binds to ligands exposed in damaged tissue and can then activate complement and its proinflammatory functions. In contrast, rat CRP, which binds to similar ligands, does not activate complement. In the present study, systemic complement depletion with cobra venom factor in adult rats subjected to middle cerebral artery occlusion did not affect cerebral infarct size, indicating that circulating complement does not contribute to injury in this model. However, we have previously reported that administration of human CRP to rats undergoing coronary artery ligation caused a marked increase in size of the resulting myocardial infarction, associated with codeposition of human CRP and rat complement in the infarcts. In the present study, we show that adult rats subjected to middle cerebral artery occlusion and then treated with human CRP similarly developed significantly larger cerebral infarcts compared with control subjects receiving human
serum albumin
. Human CRP can thus contribute to ischemic tissue damage in the brain as well as in the heart, and inhibition of CRP binding may therefore be a promising target for tissue protective acute therapeutic intervention in
stroke
as well as in myocardial infarction.
...
PMID:Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. 1554 14
In the present study, nonthyroidal illness syndrome (NTIS), which is characterized by reduction of serum triiodothyronine (T3) without elevation of thyroid-stimulating hormone (TSH), was induced by protein-energy malnutrition (PCM). Protein-energy malnutrition is a common condition and is associated with worse clinical outcome in
stroke
patients admitted to a rehabilitation service. However, little is known about NTIS in
stroke
patients. Therefore, we studied the effects of PCM and NTIS on functional dependence in 51
stroke
patients. We examined thyroid function by measuring serum free T3 (free T3), free thyroxine (free T4), and TSH. We estimated whether patients had mild NTIS (reduction of only free T3) or serious NTIS (reduction of both free T3 and free T4), examined PCM by measuring
serum albumin
, calculated body mass index (BMI) from weight and height on admission, and examined disability by obtaining the functional independence measurement (FIM). The 51 patients were divided into 2 groups according to FIM score on admission (low and high). The low-FIM group was divided into 2 subgroups according to the change in FIM score during hospitalization (improved or non-improved). Hypoalbuminemia was observed in 57% of patients, underweight in 22%, and mild NTIS in 82%; serious NTIS was not observed in any patients. Albumin and BMI were significantly higher in the high-FIM group than in the low-FIM group.
Serum albumin
concentration and BMI significantly positively correlated with free T3. Free T3 (but not albumin or BMI) was significantly higher in the improved subgroup than in the non-improved subgroup. Nonthyroidal illness syndrome after
stroke
was common and was provoked by PCM, which occurred in a high proportion of functionally dependent patients. It appears that, once
stroke
patients develop NTIS, it is difficult to achieve functional improvement. Therefore, during the recovery period after
stroke
, it is important to determine whether NTIS is present and ensure proper intensive rehabilitation and nutritional management.
...
PMID:Malnutrition and nonthyroidal illness syndrome after stroke. 1593 2
Serum albumin
protects against cell death elicited by various cytotoxic agents; however, conflicting views on the protective mechanism still remain. Hence, we have studied the ability of
serum albumin
to prevent apoptosis of human neuroblastoma SH-SY 5 Y cells elicited by four compounds known to release Ca(2+) from the endoplasmic reticulum, i.e. dotarizine, flunarizine, thapsigargin and cyclopiazonic acid. Spontaneous basal apoptosis, after 24 h incubation in Dulbecco's Modified Eagle Medium (DMEM) containing 10% serum, was 5%. Dotarizine (30--50 microM) enhanced basal apoptosis to 18--43%, flunarizine (30--50 microM) to 15%, thapsigargin (1--10 microM) to 21--35%, and cyclopiazonic acid (100 microM) to 10%. Serum deprivation augmented basal apoptosis to 20%. Under serum-free medium, 30 microM dotarizine or flunarizine drastically enhanced apoptosis to 63% and 68%, respectively; the increase was milder with 1 microM thapsigargin (37%) and 30 microM cyclopiazonic acid (27%). In serum-free medium, albumin (29 or 49 mg/ml) fully prevented the apoptotic effects of dotarizine, flunarizine and cyclopiazonic acid. The four compounds increased the cytosolic Ca(2+) concentration ([Ca(2+)](c)) in fluo-4 loaded cells; such increase developed slowly to reach a plateau after several minutes, followed by a slow decline. Albumin did not modify the kinetic parameters of such increase. In the absence of serum, dotarizine, flunarizine, thapsigargin, and cyclopiazonic acid caused mitochondrial depolarization in tetramethylrhodamine ethyl ester (TMRE)-loaded cells; depolarization was inhibited by cytoprotective concentrations of albumin. These results suggest that albumin protects cells from entering into apoptosis by preventing mitochondrial depolarization. They also suggest that inhibition of mitochondrial depolarization might become a target to develop new anti-apoptotic compounds with therapeutic neuroprotective potential in
stroke
, Alzheimer's disease, and other neurodegenerative diseases.
...
PMID:Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. 1615 37
Peroxynitrite (ONOO(-)), formed from the reaction of superoxide ((*)O(2)(-)) and nitric oxide ((*)NO), induces cellular and tissue injury, resulting in several human diseases such as
stroke
, Alzheimer's disease, and atherosclerosis. Due to the lack of endogenous enzymes responsible for ONOO(-) scavenging activity, finding a specific ONOO(-) scavenger is of considerable importance. In this study we examined the scavenging effects of zingerone from ginger against ONOO(-), intracellular RS (reactive species), and ONOO(-). The data show that zingerone can efficiently scavenge native ONOO(-) as well as ONOO(-) derived from the peroxynitrite donor 3-morpholinosydnonimine hydrochloride (SIN-1). Zingerone inhibited the formation of ONOO(-)-mediated tyrosine nitration through electron donation, nitration of bovine
serum albumin
(BSA) by ONOO(-), and intracellular RS and ONOO(-). The present study suggests that zingerone has an efficient ONOO(-) scavenging ability, which may be a potent ONOO(-) scavenger for the protection of the cellular defense activity against ONOO(-)- involved diseases.
...
PMID:Zingerone as an antioxidant against peroxynitrite. 1615 94
Increasing comorbidity with aging reduces the predictive power of cardiovascular risk factors. From the age of 70 onward, total cholesterol levels decrease, perhaps associated with changes in the composition of some lipoprotein fractions. In subjects older than 75 years, being in the lowest quartile of cholesterol, insulinemia or
serum albumin
concentrations is associated with increased mortality. Cholesterol levels below 189 mg/dL in subjects older than 75 years should be considered an early sign of unidentified comorbidity or of rapid functional decline. HDL cholesterol levels, rather than total or LDL cholesterol, were inversely associated with increased mortality from ischemic coronary disease and
stroke
appears to rise as HDL cholesterol levels fall, rather than total or LDL cholesterol. On the other hand, LDL concentrations below 106 mg/dL and HDL concentrations below 36 mg/dL were associated with an increased risk of death from infectious disease.
Stroke
incidence, in particular, ischemic
stroke
, is highest in subjects older than 75 years. HDL cholesterol levels above 35 mg/dL appear to have a protective effect against ischemic
stroke
in subjects younger than 70 years. Two interventional drug studies investigating the effects of two statins (simvastatin and pravastatin) found that in subgroups of subjects older than 75 these drugs were associated with a reduction in all-cause mortality and cardiovascular morbidity, regardless of total cholesterol levels, but had no short-term effect on cognitive function.
...
PMID:[Significance of cholesterol levels in patients 75 years or older]. 1630 66
Factors that describe the disability status of the
stroke
patient on discharge are important when starting a rehabilitation program, both from a psychosocial and a financial point of view. The objective of this study was to assess how comorbidity and
serum albumin
levels relate to rehabilitation outcome in geriatric
stroke
patients. Another aim was to assess whether
stroke
etiology (ischemic or hemorrhagic) influences these links. Medical records of 80 patients (68 ischemic and 12 hemorrhagic strokes) older than 65 years, who had suffered their first
stroke
, were investigated. Functional performance levels at admission and discharge were evaluated using the Functional Independence Measure (FIM). Length of stay in hospital was recorded.
Serum albumin
levels and comorbidity scores on admission were noted. Correlations between these variables and differences between the groups categorized according to
stroke
etiology were analyzed. In the group of geriatric
stroke
patients as a whole,
serum albumin
level was correlated with FIM score at admission and discharge. Comorbidity score was negatively correlated with length of stay. In the ischemic
stroke
subgroup,
serum albumin
level was positively correlated with length of stay and with functional gain, and comorbidity score was negatively correlated with functional gain. Analysis of the data for the hemorrhagic
stroke
subgroup revealed none of these correlations. It was concluded that
serum albumin
level and comorbidity are useful indices in geriatric ischemic
stroke
patients for predicting functional outcome and time spent in rehabilitation.
...
PMID:Serum albumin and comorbidity relative to rehabilitation outcome in geriatric stroke, and possible links with stroke etiology. 1643 95
Hypoalbuminemia is associated with increased risk of infections. The aim of this study was to determine if
serum albumin
level is an independent predictor of nosocomial pneumonia in
stroke
patients. Data of 705 consecutive ischemic
stroke
patients admitted within 24 h after
stroke
onset were analyzed retrospectively.
Serum albumin
level was measured within 36 h after
stroke
onset. Nosocomial pneumonia was found in 10.5% of
stroke
patients. Patients with pneumonia had significantly lower
serum albumin
level than those without pneumonia (31.9 +/- 7.5 g/l vs. 35.5 +/- 6.9 g/l) and
serum albumin
level was associated with risk of pneumonia on multivariate analysis (OR: 0.95, 95% CI: 0.91-0.98). Our results show that
serum albumin
level is an independent predictor of nosocomial pneumonia in
stroke
patients.
...
PMID:Serum albumin level and nosocomial pneumonia in stroke patients. 1661 50
Dysphagia following
stroke
is common problem and is of particular concern because of its potental for malnutrition. Nasogastric (NG) and percutaneous endoscopic gastrostomy (PEG) tube feeding are recognized methods for nutritional support for patients with persistent neurologic dysphagia. However, the former is associated with tube dislodgement and blockage that might compromise the patients' nutritional status. There have been few randomized prospective studies to date comparing the efficacy and safety of these 2 modes of dysphagia management in
stroke
patients. The objective of this study was to compare PEG with NG tube feeding after acute dysphagic
stroke
in terms of nutritional status and treatment failure. This was a randomized prospective clinical trial. A total of 23 consecutive patients who fulfilled the criteria were recruited from the medical wards in Hospital Universiti Kebangsaan Malaysia. The diagnosis of
stroke
(acute cerebral infarct) was based on clinical and brain computed tomographic (CT scan) findings; and the diagnosis of dysphagia was done clinically by using the 'swallowing test'. At recruitment, upper-arm skin fold thickness (triceps and biceps) and mid-arm circumference were measured; and blood was drawn for
serum albumin
level. They were then followed up at 4 weeks where the above tests were repeated. A total of 22 patients completed the study (12 patients in the NG group and 10 patients in the PEG group).
Serum albumin
levels (p = 0.045) were significantly higher in the PEG as compared to the NG group at 4 weeks post-intervention. There were statistically significant improvements in
serum albumin
level (p = 0.024) in the PEG group; and statistically significant reductions in
serum albumin
level (p = 0.047) in the NG group 4 weeks after the intervention. However, there were no significant differences in anthropometric parameters between the two groups and no significant changes in these parameters for each group 4 weeks after the intervention. Treatment failure occurred in 5 out of 10 patients (50.0%) in the NG group, but none in PEG group (p = 0.036). PEG tube feeding is more effective than NG tube feeding in improving the nutritional status (in terms of the
serum albumin
level) of patients with dysphagic
stroke
. NG tube feeding, in fact, reduced the nutritional status (in terms of the
serum albumin
level) of the patients.
...
PMID:A prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with acute dysphagic stroke. 1670 35
Cross-sectional and limited prospective evidence has suggested that inflammatory markers may predict for the risk of atrial fibrillation (AF). In a prospective cohort study, we studied the risk of incident AF among 8,870 women and men free of cardiovascular disease enrolled in the Copenhagen City Heart Study. We measured plasma fibrinogen and
serum albumin
levels at a study visit from 1991 to 1994. We identified 286 subsequent cases of AF during a mean of 7.5 years of follow-up by a validated nationwide registry of all hospitalizations. The fibrinogen levels at baseline were associated with a higher risk of AF, with a multivariate-adjusted hazard ratio for the highest versus lowest quartiles of 1.98 (95% confidence interval [CI] 0.94 to 4.17) among men and 2.14 (95% CI 1.15 to 3.96) among women. The albumin levels were inversely associated with the risk of AF among women (hazard ratio 0.47, 95% CI 0.28 to 0.77) but not among men (hazard ratio 1.01, 95% CI 0.56 to 1.84). Additional adjustment for cases of coronary heart disease, congestive heart failure, and
stroke
that occurred during follow-up did not attenuate these associations. In conclusion, higher levels of fibrinogen and lower levels of albumin were prospectively associated with a higher risk of AF, even accounting for their relation with the risk of cardiovascular disease. These findings support the hypothesis that inflammation contributes to the etiology of AF.
...
PMID:Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). 1678 25
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>